Skip to content

NOVARTIS FARMA - PROD.FARM SA — EU public contracts

NOVARTIS FARMA - PROD.FARM SA (Portugal) has won 27 public contracts worth undisclosed value in the EU in the last 12 months.

27 awardsPortugal

Categories

Pharmaceutical products: 20Antineoplastic and immunomodulating agents: 5Medicinal products for the nervous system: 2

Awarded contracts

DateBuyerSubjectValueView on TED
13 Oct 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [15 MG CÁP/ COMP]—
29 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [20 MG CÁP/COMP]—
29 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [20 MG CÁP/COMP]—
29 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - MIDOSTAURINA [25 MG CÁP]—
22 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - CANACINUMAB [150 MG/ML 1 ML SOL INJ FRS]—
22 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - CANACINUMAB [150 MG/ML 1 ML SOL INJ FRS]—
8 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]—
8 Sept 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP]—
11 Aug 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP]—
4 Aug 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2026/0002 - ONASEMNOGENE ABEPARVOVEC [2 X10E13 VG/ML 22,1 ML SOL INJ FRS]—
4 Aug 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA]—
30 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP]—
30 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP]—
30 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP]—
30 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2024/0961 - INCLISIRAN [189 MG/ML SOL INJ SERINGA]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 -OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 -OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]—
9 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA]—
9 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA]—
16 Dec 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP]—
16 Dec 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]—
16 Dec 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP]—
16 Dec 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Medicinal products for the nervous system – 2023/0671- ONASEMNOGENE ABEPARVOVEC [2 X10E13 VG/ML 22,1 ML SOL INJ FRS]—
16 Dec 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP]—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Medicinal products for the nervous system – 2023/0671 - ONASEMNOGENE ABEPARVOVEC [2 X10E13 VG/ML 22,1 ML SOL INJ FRS]—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - CANACINUMAB [150 MG/ML SOL INJ FRS]—

See open tenders that fit a company like this

Licitora matches EU public tenders to your company profile every morning. Companies like NOVARTIS FARMA - PROD.FARM SA can save hours of manual search.